This compound is a protected nucleoside derivative featuring a triazole-substituted pyrimidine base and a furodioxolane core, commonly utilized as a pharmaceutical intermediate in nucleoside synthesis. Its structure incorporates an ester-linked isobutyrate group, which serves as a synthetic handle for further functionalization in drug development.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2346620-54-8
N-benzoylcytidine
Pharmaceutical intermediate for nucleoside synthesis
5'-O-DMT-2'-O-TBDMS-Pseudouridine
Pharmaceutical intermediate for nucleoside synthesis
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
N-Benzoyl-2'-deoxyadenosine
Pharmaceutical intermediate for nucleoside synthesis
((3aR,4R,6R,6aR)-6-((4Z)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin1(2H)-yl)-2,2-dimethyltetrahydro-2H-furo(3,4-d)(1,3)dioxol-4-yl)methyl2methylpropanoate
pharmaceutical intermediate
5-Amino-1,3,4-thiadiazole-2-thiol
Impurity in acetazolamide preparation
O-Methyl (S)-Noradrenaline
pharmaceutical intermediate for norepinephrine derivatives
1-(2,3-DICHLORO-4-HYDROXYPHENYL)BUTAN-1-ONE
Pharmaceutical intermediate
[(3aR,4R,6R,6aR)-2,2-dimethyl-4-[2-oxo-4-(1,2,4-triazol-1-yl)pyrimidin-1-yl]-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl 2-methylpropanoate
KHRVXGYHTALJEX-NMFUWQPSSA-N
CC(C)C(=O)OC[C@@H]1[C@@H]2[C@H]([C@@H](O1)N3C=CC(=NC3=O)N4C=NC=N4)OC(O2)(C)C
—